[1] XU D, HU M J, WANG Y Q, et al. Antioxidant activities of quercetin and its complexes for medicinal application[J]. Molecules, 2019, 24(6):1123-1140.
[2] TAN B L, NORHAIZAN M E, LIEW W P, et al. Antioxidant and oxidative stress: a mutual interplay in age-related diseases[J]. Front Pharmacol, 2018, 9: 1162.
[3] FUENTES J, ATALA E,PASTENE E, et al. Quercetin oxidation paradoxically enhances its antioxidant and cytoprotective properties[J]. J Agric Food Chem, 2017, 65(50): 11002-11010.
[4] SOKOLOVÁ R, RAMEŠOVÁ Š, DEGANO I, et al. The oxidation of natural flavonoid quercetin[J]. Chem Commun, 2012, 48(28): 3433-3435.
[5] PINGILI R B, CHALLA S R, PAWAR A K, et al. A systematic review on hepatoprotective activity of quercetin against various drugs and toxic agents: evidence from preclinical studies[J]. Phytother Res, 2020, 34:5-32.
[6] KASIRI N, RAHMATI M, AHMADI L, et al. Therapeutic potential of quercetin on human breast cancer in different dimensions[J]. Inflammopharmacology, 2020, 28(1): 39-62.
[7] ANAND D A V, ARULMOLI R, PARASURAMAN S. Overviews of biological importance of quercetin: a bioactive flavonoid[J]. Phcog Rev, 2016, 10(20):84-89.
[8] JAKARIA M, AZAM S, JO S H, et al. Potential therapeutic targets of quercetin and its derivatives: its role in the therapy of cognitive impairment[J]. J Clin Med, 2019, 8(11):1789.
[9] CHEN C, ZHOU J, JI C Y. Quercetin: a potential drug to reverse multidrug resistance[J]. Life Sci, 2010, 87(11-12):333-338.
[10] SELVARAJ M, MICHAŁ T, KRYSTYNA S W, et al. Hepatoprotective effect of quercetin: from chemistry to medicine[J]. Food Chem Toxicol, 2017,108:365-374.
[11] ASMA V,ZAHRA S,AHMAD M, et al. Quercetin and cancer: new insights into its therapeutic efects on ovarian cancer cells[J]. Cell Biosci, 2020, 10:32.
[12] CIONE E, TORRE L T, CANNATARO C, et al. Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human microRNA modulation[J]. Molecules, 2020, 25(1): 63.
[13] KIM D H, HAROON K, HAMMAD U, et al. MicroRNA targeting by quercetin in cancer treatment and chemoprotection[J]. Pharmacol Res, 2019, 147:104346.
[14] JONES R S, PARKER M D, MORRIS M E. Quercetin, morin, luteolin, and phloretin are dietary flavonoid inhibitors of monocarboxylate transporter 6[J]. Mol Pharm, 2017, 14(9):2930-2936.
[15] TANG S M, DENG X T, ZHOU J, et al. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects[J]. Biomed Pharmacother,2020, 121:109604.
[16] NATARAJAN T D, RAMASAMY J R, PALANISAMY K, et al. Nutraceutical potentials of synergic foods: a systematic review[J]. J Ethnic Foods, 2019, 6(1): 1-7.
[17] GUPTA A, BIRHMAN K, RAHEJA I, et al. Quercetin: a wonder bioflavonoid with therapeutic potential in disease management[J]. Asian Pac J Trop Med, 2016, 6(3):248-252.
[18] D'ANDREA G. Quercetin: a flflavonol with multifaceted therapeutic applications? [J]. Fitoterapia, 2015, 106: 256-271.
[19] QU W T, ZHU W, ZHAI G Y, et al. Research progress of synthesis and biological activity of quercetin derivatives[J]. Chem Res(化学研究), 2012, 23(4):84,101-110.
[20] JIA J J, GUO Z Y, LIANG Y H, et al. Synthesis and anti-tumor activities of quercetin and its derivatives[J]. Chin Pharm J(中国药学杂志), 2016, 51(23):2013-2017.
[21] BULE M, ABDURAHMAN A, NIKFAR S, et al. Antidiabetic effect of quercetin: a systematic review and Meta-analysis of animal studies[J]. Food Chem Toxicol, 2019, 125:494-502.
[22] MASSI A, BORTOLINI O, RAGNO D, et al. Research progress in the modifification of quercetin leading to anticancer agents[J]. Molecules, 2017, 22(8): 1270.
[23] SHARMA A, KASHYAP D, SAK K, et al. Therapeutic charm of quercetin and its derivatives: a review of research and patents[J]. Pharm Pat Anal, 2018,7(1):15-32.
[24] NOBELOS P T, TZIONA P, POPTSIS A, et al. Novel polyfunctional esters of ibuprofen and ketoprofenwith hypolipidemic, lipoxygenase inhibitory and enhancedanti-inflammatory activity Panagiotis[J]. Med Chem Res, 2017,26:461-472.
[25] RASHEED A, LATHIKA G, RAJU Y P, et al. Synthesis and pharmacological evaluation of mutual prodrugs of aceclofenac with quercetin, vanillin and L-tryptophanas gastrosparing NSAIDS[J]. Med Chem Res, 2016, 25:70-82.
[26] SEO J Y, PANDEY R P, LEE J, et al. Quercetin 3-O-xyloside ameliorates acute pancreatitis in vitro via thereduction of ER stress and enhancement of apoptosis[J]. Phytomedicine, 2019, 55: 40-49.
[27] YONG H M, BAI R Y, BI F Y, et al. Synthesis, characterization, antioxidant and antimicrobial activities of starch aldehyde-quercetin conjugate[J]. Int J Biol Macromol, 2020, 156:462-470.
[28] SUMUDU W, ZIAULLAH, RUPASINGHE H. Long chain fatty acid esters of quercetin-3-O-glucoside attenuate H₂O₂-induced acute cytotoxicity in human lung fibroblasts and primary hepatocytes[J]. Molecules, 2016, 21(4):452.
[29] BURAVLEV E V, SHEVCHENKO O G, CHUKICHEVA I Y, et al. Synthesis and membrane-protective properties of aminomethyl derivatives of quercetin at the C-8 position[J]. Chem Pap, 2018, 72(1): 201-208.
[30] GUIMARES G C, PIVA H R M, ARANU'JO G C, et al. Binding investigation between M2-1 protein from hRSV and acetylated quercetin derivatives:¹H-NMR, fluorescence spectroscopy, andmolecular docking[J]. Int J Biol Macromol, 2018, 111: 33-38.
[31] NETTORE I C, ROCCA C, MANCINO G, et al. Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats[J]. J Nutr Biochem, 2019, 69: 151-162.
[32] CARULLO G, PERRI M, MANETTI F, et al. Quercetin-3-oleoyl derivatives as new GPR40 agonists: molecular docking studies and functional evaluation Gabriele[J]. Bioorg Med Chem Lett,2019, 29(14):1761-1764.
[33] ZHU J Z, ZHANG B, TAN C P, et al. α-Glucosidase inhibitors: consistency of in silico docking data with in vitro inhibitory data and inhibitory effect prediction of quercetin derivatives[J]. Food Funct, 2019, 10: 6312-6321.
[34] NICOLA S, MATTAREI A, ESPINA V, et al. Potential anti-cancer activity of 7-O-pentyl quercetin: efficient,membrane-targeted kinase inhibition and pro-oxidant effect[J]. Parmacol Res, 2017, 124: 9-19.
[35] AYAN M, MISHASIS S, KOTLA N, et al. Semisynthetic quercetin derivatives with potent antitumor activityin colon carcinoma[J]. ACS Omega, 2019, 4: 7285-7298.
[36] KOSEI Y, SYEDA H, TOHRU M, et al. 3,4,7-O-trimethyl quercetin inhibits invasion and migration of ovarian cancer cells[J]. Anticancer Res, 2017, 37 (6): 2823-2829.
[37] KELLICI T F, CHATZIATHANASIADOU M V, LEE M S, et al. Rational design and structure-activity relationship studies of quercetin-amino acid hybrids targeting the anti-apoptotic protein Bcl-xL[J]. Org Biomol Chem, 2017, 15(37):7956-7976.
[38] ALANSSARI R A, ELIAS R S, ALJADAAN S A, et al. Synthesis, Ant proliferative activity and docking study of new quercetin derivatives against MDA-MB231 breast cancer cell lines[J]. Am J Appl Sci, 2019, 16 (5): 143-161.
[39] GENÇKAL H M, ERKISA M, ALPER P, et al. Mixed ligand complexes of Co(Ⅱ), Ni(Ⅱ) and Cu(Ⅱ) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity[J]. J Biol Inorg Chem, 2020, 25(1):161-177.
[40] DASILVA W M B, DEOLIVEIRA P S, ALVES D R, et al. Synthesis of quercetin-metal complexes, in vitro and in silico anticholinesterase and antioxidant evaluation, and in vivo toxicological and anxiolitic activities[J]. Neurotox Res, 2020, 37:893-903.
[41] ROUANE A, TCHOUAR N, KERASSA A, et al. Structure-based virtual screening and drug-like of quercetin derivatives with anti-malaria activity[J]. Rev Ther Sci, 2017, 5:1-11.
[42] MAGAR R T, SOHNG J K. A review on structure, modifications and structure-activity relation of quercetin and its derivatives[J]. J Microbiol Biotechnol, 2020, 30(1): 11-20.